This information is for residents of Australia

SPIKEVAX® JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 Vaccine

SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 Vaccine is indicated for:

Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 12 years of age and older. The use of this vaccine should be in accordance with official recommendations.

PRODUCT INFORMATION

CONSUMER MEDICINE INFORMATION

How can we help you?

Report a side effect

Online: Moderna's Adverse Event Intake Portal

Connect with us

Email: WeCare@modernatx.com 
Call: 1800 344 018 Monday - Friday 8:30 AM to 7:00 PM AEST (closed holidays)